Celularity Inc. — Earnings

Most recent reported period: FY2025 (Q3) (filed for period ending 2025-09-30) · sourced from SEC EDGAR

Next earnings (estimated): Tue, December 30, 2025 122 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-09-30$5M↓-43.2%$-23M↓-43.3%-244.1%
2025-06-30$6M↓-52.6%$-25M↓-278.0%-276.6%
2025-03-31$11M↓-22.2%$-20M↑+10.3%-91.8%
2024-12-31$18M↑+49.7%
2024-09-30$9M↑+145.5%$-16M↑+82.9%-124.0%
2024-06-30$12M↑+312.2%$-6M↑+86.5%-84.0%
2024-03-31$15M↑+273.1%$-22M↑+65.6%-50.2%
2023-12-31$12M↑+193.3%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q3)

Revenue
$5M
↓-43.2% -$4M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 28 quarters

margin trajectory tells the operating-leverage story
Gross Margin
20.7%
Operating Margin↓-120.1pts
-244.1%
Net Margin↓-263.5pts
-436.7%

Go deeper